CAS:n ratkaisu norjalaisen maastohiihtäjä Martin Sundbyn dopingasiassa

Urheilun kansainvälinen välitystuomioistuin CAS on eilen antanut ratkaisun norjalaisen maastohiihtäjä Martin Sundbyn dopingasiassa. CAS päätti kumota kansainvälisen hiihtoliiton (FIS) dopinglautakunnan päätöksen ja määräsi Sundbyn kahden kuukauden kilpailukieltoon.

CAS:n lehdistötiedotteesta:

The Court of Arbitration for Sport (CAS) has upheld an appeal filed by the World Anti-Doping Agency (WADA) against the Norwegian cross country skier Martin Johnsrud Sundby and the International Ski Federation (FIS). The decision taken on 4 September 2015 by the FIS Doping Panel is set aside and the athlete is sanctioned with a period of ineligibility of two months starting on 11 July 2016 following an anti-doping rule infraction for salbutamol, a medication used by the athlete to treat asthma. The results obtained by the athlete on 13 December 2014 in Davos (SUI) and on 8 January 2015 in Toblach (ITA) are annulled.

[—]

The arbitration centred on the athlete’s administration of his asthma medication, salbutamol, with the use of a nebulizer. In its decision, the CAS Panel found that the method of ingestion (i.e. inhalation) must be distinguished from other forms of administration such as ingestion or injection, and that the dosage allowed under the FIS Anti-Doping Regulations must be understood as the prescribed “labelled” dosage. Any use of salbutamol with a nebulizer beyond such “labelled” dose, without a Therapeutic Use Exemption (TUE), constituted an anti-doping rule violation.

Koko lehdistötiedote löytyy täältä: 20.07.16 – CROSS COUNTRY SKIING – CAS decision concerning Martin Johnsrud Sundby

Koko ratkaisu löytyy täältä: CAS 2015/A/4233 WADA v. Martin Johnsrud Sundby & FIS